|
|
|||
| |||||||||||||||||||||||||||||||
Hemoglobin S arose as a protection against malarial infection. However, it has also given rise to untold misery, pain, and suffering in hundreds of thousands of people who happen to be homozygous for the sickle-cell gene. The multiple causes of the disease and its complications have been meticulously studied. There are now few diseases that are better understood biochemically, pathophysiologically, clinically, and pharmacologically than sickle cell disease. Yet this knowledge has yielded few therapeutic interventions other than those used to treat complications or symptoms of the disease. Recently, though, quantum leaps in scientific technology indicate that a cure
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |